Edwards Lifesciences News Breakdown

EW -- USA Stock  

USD 137.87  1.52  1.09%

Macroaxis does not monitor all media channels or aggregates social signals for Edwards Lifesciences. But even though we do not provide professional-grade financial sentiment analysis on Edwards Lifesciences, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Edwards Lifesciences. Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation and Edwards Lifesciences Performance.
  
a day ago at www.macroaxis.com         
Sale by Foster Stuart L of 2500 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
2 days ago at www.macroaxis.com         
Sale by Michael Mussallem of 100 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. General open market or private sale of non-derivative or derivative security
  
  
3 days ago at www.macroaxis.com         
Exercise or conversion by Michael Mussallem of 35000 shares of Edwards Lifesciences subject to Rule ...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
few days ago at www.macroaxis.com         
Acquisition by Bowlin Michael R of 3150 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Grant, award or other acquisition pursuant to Rule 16b-3
  
  
few days ago at www.macroaxis.com         
Sale by Huimin Wang of 10000 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
six days ago at enbulletin.com         
As Exxon Mobil Market Valuation Declined, Shareholder Westchester Capital Management Upped Its Holdi...
news
The EN BulletinJohnson Johnson Holding Maintained by 10-15 Associates Inc As Exxon Mobil Stock Declined, Boston ... K Reviewer Get full coverage
  
  
over a week ago at nysewired.com         
Eye Catching Stock for Investors Edwards Lifesciences Corporation
wired  News
NYSE WIRED Edwards Lifesciences Corp VP Huimin Wang Sells 3800 Shares PressOracleBfsg LLC Raises Position in Edwards Lifesciences Corp Fairfield CurrentMidday Stock Roundup Orange County Business Journal Get full coverage
  
  
over a week ago at www.talktraders.com         
Exercise or conversion by Michael Mussallem of 9000 shares of Edwards Lifesciences subject to Rule 1...
news
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Huimin Wang of 3800 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at nysewired.com         
Exercise or conversion by Michael Mussallem of 32900 shares of Edwards Lifesciences subject to Rule ...
wired  News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.talktraders.com         
Review of Price Trends Edwards Lifesciences Corporation
news
Talk Traders Get full coverage
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Michael Mussallem of 49100 shares of Edwards Lifesciences subject to Rule ...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
Sale by Foster Stuart L of 11200 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at dminute.com         
Exercise or conversion by Michael Mussallem of 32900 shares of Edwards Lifesciences subject to Rule ...
news
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Bessler Anita of 25000 shares of Edwards Lifesciences subject to Rule 16b-...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  

Build Optimal Portfolios

Diversify Your Portfolio With Edwards Lifesciences Corporation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Edwards Lifesciences Corporation to your portfolio

Investors are also looking into

Sale by Oppenheimer Peter of 5300 shares of Apple
August 19, 2018 for Oppenheimer Peter
Sale by Brian Boornazian of 200 shares of Aspen Insurance
August 19, 2018 for Brian Boornazian
Bona fide gift to William Donnelly of 6 shares of Mettler Toledo subject to Section 16
August 19, 2018 for William Donnelly
View All Premium Stories  

Edwards Lifesciences Performance

Performance against DOW
 Price Growth (%)  
      Timeline 
1
Sale by Michael Mussallem of 400 shares of Edwards Lifescien...07/31/2018
2
Sale by Foster Stuart L of 11200 shares of Edwards Lifescien...08/03/2018
3
Exercise or conversion by Michael Mussallem of 32900 shares ...08/07/2018
4
Eye Catching Stock for Investors Edwards Lifesciences Corpor...08/10/2018
5
Acquisition by Bowlin Michael R of 3150 shares of Edwards Li...08/13/2018
Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation and Edwards Lifesciences Performance. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.